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Abstract
Background: The scaphoid bone is the most commonly fractured of the carpal bones. In the Netherlands 90% of
all carpal fractures is a fracture of the scaphoid bone. The scaphoid has an essential role in functionality of the
wrist, acting as a pivot. Complications in healing can result in poor functional outcome. The scaphoid fracture is a
troublesome fracture and failure of treatment can result in avascular necrosis (up to 40%), non-union (5-21%) and
early osteo-arthritis (up to 32%) which may seriously impair wrist function. Impaired consolidation of scaphoid
fractures results in longer immobilization and more days lost at work with significant psychosocial and financial
consequences.
Initially Pulsed Electromagnetic Fields was used in the treatment of tibial pseudoarthrosis and non-union. More
recently there is evidence that physical forces can also be used in the treatment of fresh fractures, showing
accelerated healing by 30% and 71% reduction in nonunion within 12 weeks after initiation of therapy. Until now
no double blind randomized, placebo controlled trial has been conducted to investigate the effect of this
treatment on the healing of fresh fractures of the scaphoid.
Methods/Design: This is a multi center, prospective, double blind, placebo controlled, randomized trial. Study
population consists of all patients with unilateral acute scaphoid fracture. Pregnant women, patients having a life
supporting implanted electronic device, patients with additional fractures of wrist, carpal or metacarpal bones and
pre-existing impairment in wrist function are excluded. The scaphoid fracture is diagnosed by a combination of
physical and radiographic examination (CT-scanning).
Proven scaphoid fractures are treated with cast immobilization and a small Pulsed Electromagnetic Fields bone
growth stimulating device placed on the cast. Half of the devices will be disabled at random in the factory.
Study parameters are clinical consolidation, radiological consolidation evaluated by CT-scanning, functional status
of the wrist, including assessment by means of the patient rated wrist evaluation (PRWE) questionnaire and quality
of life using SF-36 health survey questionnaire.
Primary endpoint is number of scaphoid unions at six weeks, secondary endpoints are time interval to clinical and
radiological consolidation, number of non-unions, functional status at 52 weeks and non-adherence to the
treatment protocol.
Trial registration: Netherlands Trial Register (NTR): NTR2064
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Background
Fractures of the scaphoid, which is the most commonly
fractured of the carpal bones, represent 2-6% of all frac-
tures and typically occur in young, active patients aged
15 to 40 [1]. In the Netherlands 90% of all carpal frac-
tures is a fracture of the scaphoid bone. Exact incidence
is unknown, but in the Netherlands 21.000 scaphoid
fractures are suspected and subsequently treated as such
each year [2,3]. Probably 15 to 20% represent real frac-
tures [4].
The scaphoid bone articulates with 5 surrounding
bones in the wrist and therefore has an essential role in
functionality of the wrist, acting as a pivot. Treatment of
scaphoid fractures can be very troublesome and failure
can result in avascular necrosis (up to 40%), non-union
of the fracture (up to 21%) and subsequently early
osteo-arthritis (up to 32%) [1,5-7]. In dislocated frac-
tures complication rates are even higher [8]. Part of the
explanation for this high incidence of avascular necrosis
can be found in the special blood supply of the scaphoid
bone. Branches of the radial artery enter the os scaphoi-
deus dorsally, thus supplying the bone from distal to
proximal. Therefore fractures of the mid or distal third
of the scaphoid can result in avascular necrosis of the
proximal part of the bone. Non-union is defined as the
absence of healing at four to six months after injury.
This may be due to delay in treatment, inadequate
immobilization, localization of the fracture, instability
due to displacement of the fracture fragments or combi-
nation with ligamentous injury of the carpus. All these
conditions are responsible for severe impairment in
wrist function and even permanent disability. Studies
have shown that untreated non-unions of the scaphoid
will lead to osteo-arthritis in 75% of all cases within 6-9
years and even up to 100% in 10 years, usually leading
to permanent disability [9]. Therefore, treatment failure
may have severe socio-economical consequences.
In addition impaired consolidation of scaphoid frac-
tures results in longer immobilization and loss of func-
tion. Since the patient population consists mainly of
young, productive people, prolonged immobilization and
function loss leads to more days of lost at work with
again more economical and social consequences. Studies
showed that even uncomplicated healing leads to a mean
employment interruption of 155 days. In case of compli-
cated healing conditions like non-union of the fracture,
the median period of disability is even 296 days [10].
Current treatment strategies are unable to deal with
this problem. The number of complications following
conventional treatment, being immobilization in a cast
is, as mentioned before, quite high and surgery is gener-
ally performed only if complications in healing occur.
Results of operative treatment are variable [11] and
furthermore operative treatment for complicated healing
of scaphoid fractures (e.g. delayed or non-union) is
often initiated in a late phase, most often months after
the fracture occurred, which again can have severe
socio-economical consequences [10].
The exact incidence of scaphoid fractures in the Neth-
erlands is difficult to estimate. On the one hand, litera-
ture indicates that approximately 24.000 carpal fractures
(of which 21.000 scaphoid fractures) are being suspected
[1-3]. On the other hand, the estimated incidence of
true scaphoid fractures is 35 per year in a hospital with
an adherence of 250.000 people. Furthermore, literature
suggests that true incidence among suspected fractures
of the scaphoid is around 15 to 20% [4,12,13]. On a
national level, this would indicate that the total number
of diagnosed scaphoid fractures amounts to approxi-
mately 3.000. Previous studies showed that even uncom-
plicated healing leads to a mean employment
interruption of 155 days or 22 weeks [10]. The hypoth-
esis is that the use of PEMF can shorten this duration
by 30 percent [14]. If we assume that 25% of all sca-
phoid fractures could be treated with PEMF, then this
would lead to an increase in total treatment costs of 750
(25% of 3.000) * €1.250 (costs of PEMF) = €937.500.
Still, from a societal perspective, the use of PEMF
could potentially lead to a decrease in workdays lost of
750 (25% of 3.000)* 46 days (30% of 155 days) = 34.500
days. If we calculate the costs of these workdays lost by
using the friction cost method, then this reduction
could potentially lead to cost-savings of 34.500 *
€303.21(cost per day of work lost based on the average
of the productivity costs per hour as reported in Oos-
tenbrink et al [15] assuming a work day of 8 hours) *
0.8 (correction factor) = €8.368.596
Physical forces used in fracture healing are direct cur-
rent, Pulsed Electromagnetic Fields (PEMF) and ultra-
sound. An important hypothesis in the application of
physical forces on fracture sites is that strain-generated
electrical potentials may be a regulatory signal for cellular
processes of bone formation [16]. Inductively-coupled
electromagnetic fields have been used in medicine since
1974 [17]. Several studies showed that physical forces sti-
mulate osteogenesis, in that callus was formed around
the cathode [5,18]. The first double-blind study of appli-
cation of PEMF was on fractures with delayed union of
the tibia, which showed a significantly better healing rate
than the control group [19]. In non-union scaphoid frac-
tures Bora et al reported a 71% reduction in non-union
within twelve weeks after initiating the electrical stimula-
tion [20]. Later this rather invasive method was replaced
by PEMF, a non-invasive technique.
Several clinical trials have been conducted to test
whether physical forces can also be used in treating
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fresh fractures [21,22]. The use of pulsed electromag-
netic fields (PEMF) in the treatment of ununited tibial
fractures is a promising non-invasive technique which
may offer an effective alternative to surgery [23]. How-
ever, its effect has never been investigated in fresh sca-
phoid fractures, although there is evidence that
treatment of fresh scaphoid fractures by physical forces
(ultra sound) accelerates healing by 30% [14].
We therefore want to investigate whether the use of
PEMF in fresh scaphoid fractures accelerates consolida-
tion and reduces the incidence of disabling wrist condi-
tions like scaphoid non-union or osteonecrosis. When
considering the patient group, influence of sex, age or
cultural background on healing of scaphoid fractures
has never been reported. Relating to patient compliance,
a non-published pilot study using the PEMF device
showed good patient compliance with a drop out per-
centage of less than 10%.
This study is the first double blind randomized, pla-
cebo controlled trial to investigate the effect of pulsed
electromagnetic fields on the healing of fresh fractures
of the scaphoid and investigate the effects of this treat-
ment on consolidation and complications of treatment.
The aim of our study is therefore:
1. To determine whether the use of bone-growth sti-
mulation by means of pulsed electromagnetic fields in
acute scaphoid fractures will accelerate healing both
clinically and radiologically.
Consequences of accelerated consolidation on time off
work and social well-being will also be investigated.
2. To determine whether the use of PEMF in acute
scaphoid fractures will decrease the incidence of non-
unions and avascular necrosis of the scaphoid and there-
fore the number of secondary surgical interventions.
The association of mal-union and non-union of the sca-
phoid fracture with clinical outcome will also be
investigated.
3. To investigate the effect of PEMF in acute scaphoid
fractures on functional outcome
4. To investigate the potential cost-effectiveness of
PEMF from a societal perspective when compared with
care as usual.
Methods/Design
This is a multi center, double blind, randomized, pla-
cebo-controlled trial. Four centers will participate in this
trial, investigating the effect of pulsed electromagnetic
fields on union of fresh scaphoid fractures.
The estimated effect of the investigated intervention is
as described previously. All unilateral scaphoid fractures,
types A1, A2, B1, B2 and B3 (all stable and unstable
acute fractures except the dislocated and comminuted
ones according to the Herbert classification) will be
included [24].
Exclusion criteria are pregnancy, presence of a life-
supporting implanted electronical device, additional
fractures of wrist, carpal or metacarpal bones and pre-
existing impairment in wrist function. If necessary, preg-
nancy will be excluded by means of testing. Study para-
meters are radiological consolidation, clinical
consolidation, quality of life, functional outcome and
non-union of the fracture. Primary endpoint is radiolo-
gical proof of union of the scaphoid fracture at six
weeks after initiation of the electromagnetic stimulation.
Secondary endpoints are radiological and clinical conso-
lidation at 24 weeks (non-union), 52 weeks and func-
tional outcome and quality of life at 52 weeks.
Furthermore adherence to the treatment protocol will
be checked. The choice for the primary endpoint is
based on previous data from studies from Mayr [14],
Heckman [21] and Kristiansen [22] where significant
acceleration of healing in acute (scaphoid) fractures was
based on data collected at six weeks after initiation of
stimulation.
Trabecular bridging (CT sign confirming fracture
healing) at six weeks showed 81% fracture healing in the
group with stimulated fractures versus 55% in the con-
trol group [14].
If a power analysis is conducted on base of this infor-
mation, a group of about 54 patients in each group is
needed. (Type alpha error 0.05, type beta error 0.20,
outcome intervention group 81%, outcome control
group 55%, calculated drop out 15%). Taking the esti-
mated incidence into account, a total study group of
100 to 110 patients should be included within a period
of 12-24 months, among 4 medical centers with an
adherence of about 1.5 million people. Secondary end-
points are important because long-term consequences of
delayed or complicated healing can be reliably predicted
at 52 weeks.
All patients suspected of having an acute scaphoid
fracture will be treated with cast immobilization. Pre-
sence of a scaphoid fracture is diagnosed by a combina-
tion of physical and radiographic examination. Previous
studies showed that conventional radiographic examina-
tion is inadequate in diagnosing a possible occult sca-
phoid fracture. (Immediately after injury, up to 65% of
scaphoid fractures remain radiographically occult with
conventional radiographic examination.) [25,26] There-
fore, if no apparent fracture line is seen on the initial X-
rays, a CT scan will be performed within 3 to 8 days to
confirm the diagnosis. Criteria for a bone fracture on
(multidetector) CT images are the presence of a sharp
lucent line within the trabecular bone pattern, a break
in the continuity of the cortex, a sharp step in the cor-
tex, or a dislocation of bone fragments. Multidetector
CT has an unusually high acuratesse in detecting sca-
phoid fractures, resulting in up to 95% sensitivity and
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100% specificity for the identification of cortical involve-
ment of scaphoid fractures [26,27]. Herbert’s classifica-
tion of scaphoid fractures will be used [28]. The criteria
mentioned earlier will determine in- or exclusion from
the trial.
The small PEMF device (supplied by commercial sup-
port) will be placed on the cast within five days after
diagnosing the fracture and will be applied for 24 hours
a day continuously. Dependent on fracture consolida-
tion, the device will be removed after six to twelve
weeks. The cast will be a lower arm cast with the first
metacarpal bone and both phalanges immobilized. Since
the position of the thumb and the hand have no adverse
effect on the displacement of the fracture or it’s consoli-
dation, this neutral plaster is chosen [29,30].
Half of the PEMF devices will be disabled at random
in the factory. These disabled devices will give outward
signs of normal function but will not generate a signal.
The investigators will be unaware of the device’s func-
tionality. The patients will not be able to determine
whether the device is working or not. At study comple-
tion, device serial numbers will be used to determine
which patients received a working device. The company
supplying the PEMF-devices will have no knowledge of
patient outcome. Follow up will take place at six, nine,
twelve, twenty-four and fifty-two weeks after diagnosis
of the fractured scaphoid. At these times the cast will be
removed and physical and radiological examination will
be performed to determine fracture consolidation. Physi-
cal examination includes investigating 4 separate items.
The first item is presence of pain on local pressure on
the anatomic snuffbox (ASB). The ASB is defined as the
groove between the tendons of extensor pollicis longus
on the ulnar side and extensor pollicis brevis and abduc-
tor pollicis longus on the radial side. Tenderness is eli-
cited by digital pressure in the floor of this groove.
Sensitivity of this test is 100%, yet its specificity is low
(9%) [31]. Some studies however, report a specificity of
up to 57% when testing specifically for tubercle tender-
ness [32]. The second item to be tested is tenderness
with longitudinal compression of the scaphoid; tender-
ness is elicited by clasping the extended, mid-abducted
thumb between the examiner’s thumb and index finger
and pressing towards the scaphoid. In some studies a
specificity up to 80% is reported for this test [33].
The third item to be tested is wrist movement. Wrist
movement is defined as the range of motion the wrist
can make in dorsal flexion, palmar flexion, radial and
ulnar deviation. These movements are recorded in
degrees. The sum of these degrees is expressed as a per-
centage of that of the opposite wrist to take individual
variation into account [34]. A loss of more than 25% of
wrist movement is considered to be significant [35].
Last, grip strength is measured with help of a JAMAR
dynamometer. Grip strength of both the injured and the
non-injured site will be tested. All tests will be com-
pared with the opposite unaffected side.
Since standard X-rays are unreliable in determining
the degree of consolidation, additional CT-scans will be
performed in the follow up after 6 weeks, 12 weeks, 24
weeks and 52 weeks. Quantification of fracture healing
with the CT scan is based on formation of callus along
the fracture and trabecular ridging [36]. The CT scan at
6 weeks will be important for determining the portion
of fractures rapidly healed and determining outcome for
the primary endpoint. The CT scan at 12 weeks is
important for establishing the portion of patients with a
scaphoid fracture showing signs of delayed (and even-
tually non-) union. The CT-scan at 52 weeks is particu-
larly important for 2 reasons. First of all identification of
delayed unions (longer than 4 months) can be con-
firmed. Secondly, if consolidation was established before,
it can be checked at later follow up dates if that conclu-
sion wasn’t premature and the fractures are in fact
healed. Former studies have pointed out that follow up
may reveal non-unions whereas the fracture was consid-
ered to be consolidated before [37]. When the fracture
has both clinically and radiologically consolidated the
plaster will be removed. If the fracture has not consoli-
dated; a new plaster will be made. The timing of the
removal of the plaster can vary between six or twelve
weeks. Only patients who need immobilization of the
fracture (not consolidated fractures) will have a PEMF
device on them, for in clinically and radiographically
consolidated patients there is no need for further treat-
ment. All patients will receive the same follow up, as
described above. If the fracture is not consolidated after
twelve weeks, at physical or radiographic examination,
yet the patient has no pain, the treatment is finished. If
the patient has got pain, he will get a removable splint.
In addition to the physical and radiographic examina-
tion, patients will be required to fill in a questionnaire: a
SF health survey 36. The SF36 questionnaire appears to be
a valid and reliable instrument to measure pain and psy-
chosocial well-being [38]. This will be done after inclusion
in the trial, before applying the PEMF device, at 6,9,12,24
and at 52 weeks. For assessment of functional deficit, dis-
ability and pain level, the Patient Rated Wrist Evaluation
(PRWE) will be used. The PRWE is an easy 15-item ques-
tionnaire designed to measure wrist pain and disability in
activities of daily living. The PRWE allows patients to rate
their levels of wrist pain and disability.
Studies showed that the total PRWE’s score’s reliabil-
ity was excellent over both the short term (2-7 days)
and the long term (1 year) [39]. Patients will be asked to
fill out this questionnaire at 6,9,12,24 and 52 weeks after
inclusion.
Follow up will end 52 weeks after inclusion (Figure 1).
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We have not conducted preliminary studies on this
subject. Yet there is sufficient literature available proving
the effectiveness of this intervention, as mentioned
before. There is however some experience with the use
of pulsed electromagnetic fields in the treatment of
scaphoid fractures in the medical centers in Arnhem,
Nijmegen and Hoorn. Considering the hospital in
Hoorn, with an adherence of 175.000 patients, pulsed
electromagnetic fields-treatment of 13 patients within a
period of 9 months has taken place. In Nijmegen, where
Figure 1 Flowchart.
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the participating hospital has an adherence of 275.000
patients, 37 patients with a scaphoid fracture were initi-
ally treated with PEMF within a period of 2 years. So
concerning the quantitative feasibility of this study, if we
extrapolate these numbers to the total region of 4 hospi-
tals with an adherence of around 1.5 million patients,
we suspect that inclusion of 100 patients within a period
of 1 year should be possible.
Concerning the practical feasibility of the study, the
device will be attached to the plaster with additional
soft cast after the transducer coil has been applied on
the skin above the fracture site. The patient cannot
move or displace the device. Pilot studies using the
PEMF device for the same indication have confirmed
that most patients do not experience any inconvenience
because of the device. No adverse effects of PEMF have
been recorded. So no limitations are expected concern-
ing the feasibility of the intervention.
The research question for the economic evaluation is:
Is the use of PEMF for fresh scaphoid fractures poten-
tially cost-effective when compared with care as usual
from a societal point of view?
The economic evaluation will include both a cost-
effectiveness analysis and a cost-utility analysis from a
societal perspective. For the cost-effectiveness analysis,
the incremental cost-effectiveness ratio (ICER) will be
calculated and expressed as the incremental costs per
consolidation (see power-analysis). This means that the
difference in total treatment costs between the interven-
tion group and care as usual will be divided by their dif-
ference in effectiveness (i.e. consolidation). In addition,
for the cost-utility analysis, the incremental costs per
Quality Adjusted Life Years will be calculated. For this
purpose, the health states of the SF36, a questionnaire
developed to measure health related quality of life, will
be converted to utilities.
Regarding cost-analysis
Resource use of the following cost-categories will be
measured:
Within health care: control visits, X-ray, CT-scan,
emergency visits, costs of the intervention (i.e. device).
Outside health care: productivity loss, travel costs. The
total number of workdays lost will be measured by
using modules of the PRODISQ, Productivity and Dis-
ease Questionnaire at baseline, 12, 24 and 52 weeks
[40]. The costs of productivity loss will be calculated
by means of the friction cost method, based on the
average standardized wages per hour. The friction cost
method takes into account the time, which is needed
to replace a sick employee in order to restore the pro-
duction at the original level [15]. Similar to the clinical
study, the time horizon for the economic evaluation
will be from the moment of inclusion until 12 months
follow-up. Within the context of this study, no costs
occur after one year, therefore discounting will not be
applied. Total treatment costs will be calculated by
multiplying volumes of use with the costs per unit.
Unit costs will be derived from the hospital financial
department or the Dutch guidelines for cost-calcula-
tion [15] Indirect costs (in this case general hospital
overhead) will be allocated to the direct costs as an
overall percentage, in accordance with the Dutch
guidelines for cost calculation.
Regarding the analysis
Data will be analyzed according to the intention-to-treat
principle. Confidence intervals surrounding the mean
differential costs will be calculated by the bootstrap
method. This method estimates the sampling distribu-
tion of a statistic with replacement from original data
[41] In addition, bootstrap analysis will also be used to
quantify the uncertainty surrounding the incremental
cost-effectiveness ratio (ICER) [42].
Results of this analysis will be presented in cost-effec-
tiveness planes and acceptability curves. A cost-effective-
ness plane is a graphical presentation of four situations
or quadrants in which additional costs and additional
health outcome effects of a new therapy are compared
to care as usual. The acceptability curve shows the prob-
ability of a new therapy being more cost-effective than
the usual treatments for various threshold values, i.e. the
maximum amount society is willing to pay.
Regarding patient outcome analysis
As described above, the primary outcome for the cost-
effectiveness analysis will be the number of consoli-
dated fractures. In addition, the outcome for the cost-
utility analysis will be QALY, based on the scores of
the SF-36. The SF-36 is developed to measure general
health related quality of life [43]. The survey consists
of 36 items and questions, which present respondents
with choices about their perception of health over the
last week. The following dimensions are included; phy-
sical functioning, role limitations due to physical pro-
blems, bodily pain, general health, vitality, social
functioning, role limitations due to emotional pro-
blems and mental health. The scores from the SF-36
can be converted to utilities and hence to QALY’s
by using the scoring model as developed by Brazier J
et al. [44]
Ethics and consent
The study protocol conforms to the Helskinki Declara-
tion and to local legislation. The local medical ethics
committee [45] reviewed and approved the study
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protocol. All patients have to provide written informed
consent before participation in the study.
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